Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility

聚乙二醇免疫原性对植入物生物相容性的影响

基本信息

  • 批准号:
    10798522
  • 负责人:
  • 金额:
    $ 2.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Poly(ethylene glycol) (PEG) based hydrogels are widely used in medical devices and are being studied for the delivery of protein and cellular therapeutics. While these biomaterials are widely regarded as biologically inert, concerns over PEG’s immunogenicity have emerged in recent years. It has been estimated that 20-30% of the population has antibodies against PEG due to exposure via pharmaceuticals, cosmetics, and other PEG- containing products. While an anti-PEG immune response has been found to reduce the efficacy of intravenously administered PEGylated drugs, the impact on the biocompatibility of PEG hydrogels has not previously been studied and is currently unknown. To address this knowledge gap, this project has two Specific Aims that encompass comprehensive in vivo testing to evaluate the host response to PEG hydrogels of varying physical and chemical properties. In these experiments, PEG hydrogels will be implanted subcutaneously in mice, and the host response will be evaluated at early, intermediate, and late timepoints using histology, immunohistochemistry, flow cytometry, and blood testing. The key comparison in these experiments will be between animals conditioned to mount an anti-PEG response and immunologically naïve controls. The project has two Specific Aims. Aim 1 focuses on PEG hydrogel formulations that lack hydrolytically and enzymatically cleavable linkers. Hydrogels that differ in modulus, crosslinking chemistry, and functionalization with cell-adhesive peptides will be systematically studied. Aim 2 focuses on PEG hydrogel formulations that contain hydrolytically and enzymatically degradable linkers. In addition to evaluating the host response, the impact of the anti-PEG immune response on the in vivo degradation rate of these hydrogels will be investigated via non-invasive imaging in a longitudinal study. The results of this project will either alleviate concerns over PEG immunogenicity for biomaterial implants or motivate future investigations on strategies to mitigate its effects.
项目摘要 基于聚(乙二醇)(PEG)的水凝胶广泛用于医疗装置中,并且正在研究其用途。 递送蛋白质和细胞治疗剂。虽然这些生物材料被广泛认为是生物惰性的, 近年来出现了对PEG免疫原性的关注。据估计,20-30%的 人群由于通过药物、化妆品和其他PEG接触而产生抗PEG抗体, 包含产品。虽然已经发现抗PEG免疫应答降低了免疫治疗的功效, 静脉内施用PEG化药物,对PEG水凝胶的生物相容性的影响没有 以前被研究过,现在还不知道。为了解决这一知识差距,该项目有两个 具体目的包括全面的体内试验,以评价宿主对PEG水凝胶的反应 具有不同的物理和化学性质。在这些实验中,PEG水凝胶将被植入 小鼠皮下注射,并在早期、中期和晚期时间点评价宿主反应 使用组织学、免疫组织化学、流式细胞术和血液测试。关键的比较 实验将在适应于产生抗PEG应答的动物和免疫学上未处理的动物之间进行 对照该项目有两个具体目标。目的1集中于PEG水凝胶制剂,其缺乏 水解和酶促可裂解的接头。水凝胶在模量、交联化学和生物相容性方面不同, 将系统地研究细胞粘附肽的功能化。目标2关注PEG水凝胶 含有水解和酶可降解的连接体的制剂。除了评估主机 响应,抗PEG免疫响应对这些水凝胶的体内降解速率的影响将 在纵向研究中通过非侵入性成像进行研究。该项目的结果要么会缓解 对生物材料植入物的PEG免疫原性的担忧或促使未来研究策略, 减轻其影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Alge其他文献

Daniel Alge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Alge', 18)}}的其他基金

ALTERING THE IMMUNE LANDSCAPE TO AUGMENT BONE REGENERATION
改变免疫景观以增强骨再生
  • 批准号:
    10727797
  • 财政年份:
    2023
  • 资助金额:
    $ 2.97万
  • 项目类别:
Development of a minimally invasive optical biosensor to improve hyperphosphatemia management
开发微创光学生物传感器以改善高磷血症管理
  • 批准号:
    10742278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.97万
  • 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
  • 批准号:
    10504301
  • 财政年份:
    2022
  • 资助金额:
    $ 2.97万
  • 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
  • 批准号:
    10697334
  • 财政年份:
    2022
  • 资助金额:
    $ 2.97万
  • 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
  • 批准号:
    10809875
  • 财政年份:
    2022
  • 资助金额:
    $ 2.97万
  • 项目类别:
Impact of the Anti-PEG Response on the Efficacy of PEG Hydrogel-Mediated Bone Regeneration
抗 PEG 反应对 PEG 水凝胶介导的骨再生功效的影响
  • 批准号:
    9890921
  • 财政年份:
    2019
  • 资助金额:
    $ 2.97万
  • 项目类别:
Osteoinductive Microgel-Based Scaffolds for hMSC Delivery
用于 hMSC 输送的骨诱导微凝胶支架
  • 批准号:
    9299161
  • 财政年份:
    2017
  • 资助金额:
    $ 2.97万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.97万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了